New CLO variant draws scrutiny from US insurance regulator

By Kathryn Gaw, Lisa Fu

The National Association of Insurance Commissioners is fast-tracking a decision on whether securitised products such as Apollo’s AMAPS and APADS can be sold to insurers as bonds, Robert Fettman, a partner at law firm DLA Piper, told Creditflux

Subscriber-only article

This article is available only to Creditflux subscribers and free trial users within 30 days of publication.

Already a subscriber? Not logged in? Click here to login.

If you have not already done so,
you may request a FREE TRIAL by clicking here

This trial will give you:
  • 4-weeks' free online access to our
    most recent subscriber-only articles
  • Daily breaking news alert sent by email
  • A print copy of Creditflux

If you currently have a free trial, you will see this message when you try to view articles older than 30 days.

TAGS: Regulation CLO Apollo North America